Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
18 /100
LOW RISK
Score updated Oct 13, 2026

CAI — Caris Life Sciences, Inc. Dilution Risk Tracker

Track CAI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CAI — Get alerts when the score changes →

As of October 13, 2026, Caris Life Sciences, Inc. (CAI) has a DilutionWatch DilutionScore of 18/100, rated LOW dilution risk. Caris Life Sciences, Inc. has a market capitalization of $8.39B, 282.60M shares outstanding, 203 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway—
📊 Float Risk
57
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CAI.
🔔 Track CAI — Get forecast alerts →

Market Data

Market Cap$8.39B
Shares Outstanding282.60M
Float103.40M
Cash$922.10M
Debt$393.15M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore18/100DilutionWatch score record
Shares Outstanding282.60MVerified float table or market cache
Public Float103.40MVerified float table or market cache
Market Cap$8.39BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 4, 8-K 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 16.3% shares (2026Q1 vs prior)
203 institutional holders · 175.01M shares
#1 FMR LLC 30.79M shares
#2 COATUE MANAGEMENT LLC 19.64M shares
#3 J. H. Whitney Equity Partners VI, LLC 18.26M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest13.89M
Days to Cover2.5
% of Float13.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-03
8-K 8K EVENT 2026-04-02
4 INSIDER TRANSACTION 2026-03-10
4 INSIDER TRANSACTION 2026-03-10
4 INSIDER TRANSACTION 2026-03-10
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CAI Dilution Snapshot

Caris Life Sciences, Inc. (CAI) has a DilutionScore of 18/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CAI's DilutionScore has held steady at 18/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202618/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CAI shares outstanding have increased 0.0% from 282.58M (Mar 2026) to 282.68M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 2026282.68M103.40M▼ 0.01%
May 28, 2026282.68M103.41M▼ 0.10%
May 22, 2026282.68M103.51M▲ 0.01%
May 17, 2026282.68M103.50M▲ 5.05%
May 16, 2026282.68M98.53M▲ 2.05%
May 12, 2026282.66M96.55M▲ 0.01%
May 10, 2026282.66M96.54M▲ 0.03%
Apr 27, 2026282.66M96.51M▲ 0.06%
Apr 26, 2026282.66M96.46M▼ 0.65%
Apr 04, 2026282.58M97.08M▼ 0.64%
Apr 03, 2026282.58M97.71M▼ 20.37%
Mar 26, 2026282.58M122.71M▲ 25.48%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CAI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CAI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CAI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CAI
CAI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.